Docstoc

2012 Aarkstore.com | Dendreon Corporation – Product Pipeline Review – 2012

Document Sample
2012 Aarkstore.com | Dendreon Corporation – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Dendreon Corporation – Product Pipeline Review – 2012



You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Market Direct’s pharmaceuticals report, “Dendreon Corporation - Product
Pipeline Review - 2012” provides data on the Dendreon Corporation’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Dendreon Corporation’s corporate website, SEC filings,
investor presentations and featured press releases, both from Dendreon
Corporation and industry-specific third party sources, put together by Global
Markets Direct’s team.

Scope

- Dendreon Corporation - Brief Dendreon Corporation overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Dendreon Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 4
List of Figures 5
Dendreon Corporation Snapshot 6
Dendreon Corporation Overview 6
Key Information 6
Key Facts 6
Emisphere Technologies, Inc. – Research and Development Overview 7
Key Therapeutic Areas 7
Emisphere Technologies, Inc. – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Pipeline Products – Combination Treatment Modalities 12
Emisphere Technologies, Inc. – Pipeline Products Glance 13
Emisphere Technologies, Inc. Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Emisphere Technologies, Inc. – Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
Emisphere Technologies, Inc. – Drug Profiles 16
Anti-Serine Protease Monoclonal Antibody Program 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CA-9 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Carcinoembryonic Antigen 18
Product Description 18




List of Figures

List of Tables are also include.
For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1




Daiichi Sankyo Company, Limited – Product Pipeline Review – 2012

endreon Corporation – Product Pipeline Review – 2012

Elan Corporation, plc – Product Pipeline Review – 2012

Emisphere Technologies, Inc. – Product Pipeline Review – 2012

H. Lundbeck A/S – Product Pipeline Review – 2012

Baxter International Inc. – Product Pipeline Review – 2012

BioCryst Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Columbia Laboratories Inc. – Product Pipeline Review – 2012

Corcept Therapeutics Incorporated – Product Pipeline Review – 2012

Curis, Inc. – Product Pipeline Review – 2012




Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:23
posted:8/30/2012
language:English
pages:4
Description: This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Dendreon Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Dendreon Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.